ARTICLE | Company News
Cambridge Antibody, Merck deal
November 4, 2002 8:00 AM UTC
CAT granted MRK a license to its human phage antibody libraries. MRK will use the libraries for R&D across a range of therapeutic areas. CAT will receive upfront license and technology access fees. CA...